Clinical Trial Update: Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oral dehydroepiandrosterone (DHEA) for postmenopausal women has completed, assessing effects on sexual function, wellbeing, and vasom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder
• Menopause

Drugs mentioned

• DHEA (dehydroepiandrosterone)

Snippet

Sponsor: Monash University | Conditions: Quality of Life, Menopausal Syndrome | Phase 3 | Status: COMPLETED